FOLR2 and breast cancer: This finding supports previously published work by Nalio Ramos et al.,119 in which they demonstrated that macrophages expressing the resident macrophage marker FOLR2 positively correlate with CD8+ T cells, B cells, dendritic cells, and tertiary lymphoid structures, and that this correlates with better outcome in breast cancer patients.